SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Health Services Pricing

Insurers must be forced to justify huge annual increases | Daily Mail Online

Insurers must be forced to justify huge annual increases | Daily Mail Online

Pensioners are the worst-hit because they are less likely to look for deals online. The calls for insurers to be forced to justify to customers why they have hiked their premium come after a Money Mail investigation found long-standing customers are being over-charged by up to £1,000, while insurers offer new customers loss-making introductory deals. […]

La. Politics: Lawmakers looking into prescription drug pricing | Daily Comet

La. Politics: Lawmakers looking into prescription drug pricing | Daily Comet

A set of bills moving through the state Legislature’s ongoing regular session would create new layers of disclosure in regard to prescription drug pricing in Louisiana. The policy push has caught the attention of the Pharmaceutical Research and Manufacturers of America, which represents companies that research, develop and market medicines. They’re also companies that are […]

New price for muscular dystrophy drug draws criticism | CNBC

New price for muscular dystrophy drug draws criticism | CNBC

Deflazacort wasn’t approved in the U.S., so McSherry and a number of other families of kids with Duchenne imported the drug from overseas. She says it cost about $1,200 a year out of pocket. Monday, deflazacort got a new price tag: $35,000 a year for a patient in the U.S. weighing 25 kilograms, or about […]

Big Pharma Losing Leverage as Payers Raise Pressure on Price | Bloomberg

Big Pharma Losing Leverage as Payers Raise Pressure on Price | Bloomberg

The world’s biggest drugmakers don’t have the muscle they used to have. Pharmaceutical and biotechnology giants are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That’s raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets. “You had an […]

Fair pricing or pricing for profit? | CMAJ News

Fair pricing or pricing for profit? | CMAJ News

If you had $500 000, would you provide drugs to one person who has a rare disease for a year, cure ten people of hepatitis C, or treat 500 with diabetes? This sort of question is plaguing cash-strapped public pharmacare programs in Canada. What is fair pricing? It’s a question making headlines and prompting debate, such […]

Stentmakers want Centre to apply differential pricing | OptionsTip

Stentmakers want Centre to apply differential pricing | OptionsTip

The corresponding average MRPs before the price control stood at ₹45,100 and ₹1.21 lakh respectively. With the government rejecting applications from Abbott and Medtronic to withdraw their advanced DES, Medical Technology Association of India (MTaI) said if all the DES were treated as same on pricing front, then companies must be allowed to decide to […]

How do you price a new kind of healthcare service? | Sherpaa

How do you price a new kind of healthcare service? | Sherpaa

Pricing is much more important than product As Tom Whitwell puts it in this exceptional piece about pricing: Prices are interesting because they inspire such strong emotions. Responding to price is hard-wired into our brains. When we see something expensive, we know immediately — without thinking — that it isn’t for us. Sherpaa is a fundamentally new way of communicating […]

Two states probe Eli Lilly over high insulin pricing | Axios

Two states probe Eli Lilly over high insulin pricing | Axios

Pharmaceutical giant Eli Lilly is facing civil investigations from attorneys general in New Mexico and Washington into its insulin prices, according to Lilly’s latest quarterly filing. Washington’s attorney general is also looking into Lilly’s relationships with pharmacy benefit mangers — the middlemen who negotiate drug prices for insurance companies and employers. Read complete article here: […]

Amgen: The Bear Case From a Bull | Madison.com

Amgen: The Bear Case From a Bull | Madison.com

Long story short, the recent introduction of Inflectra, Pfizer’s (NYSE: PFE) biosimilar to Johnson & Johnson’s (NYSE: JNJ) Remicade, could negatively affect the pricing power for anti-inflammatory drugs as a whole. After all, Pfizer has already announced that Inflectra will initially be sold at a 15% discount to the wholesaler acquisition cost of J&J’s Remicade, which may spur a round of deeper […]

Four Areas Your Yearly Pricing Review Might Be Missing | HealthLeaders Media

Four Areas Your Yearly Pricing Review Might Be Missing | HealthLeaders Media

Hospitals and health systems face a number of important decisions when determining how to price services and delivery of care. Your ability to regularly review and align your pricing strategy has become even more significant in the face of mergers and acquisitions, software conversions, and healthcare consumers responsible for increasing deductibles. Incorrectly set prices can […]